HU 308 from Tocris Bioscience, a Bio-Techne Brand | Biocompare.com

Supplier Images

HU 308

Potent and selective CB2 agonist

Be the first to write a review!

Citations:

Supplier Page from
Tocris Bioscience, a Bio-Techne Brand for
HU 308

Description

Potent and selective CB2 agonist

Product Specs
ItemHU 308
CompanyTocris Bioscience, a Bio-Techne Brand
Price $380.00Supplier Page View Company Product Page
Catalog Number3088/10
Quantity10 mg (also 50 mg)
Purity98%
Molecular Weight414.62
Molecule Name(1S,4S,5S)-4-[4-(1,1-Dimethylheptyl)-2,6-dimethoxyphenyl]-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-methanol
FormulaC27H42O3
StorageStore at -20°C

Specifications/Features

Sizes Available: 10 mg (also 50 mg)

Add to Compare List

Tocris Bioscience, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956
Fax: 1 (612) 656-4400

Company Profile

Website: http://www.tocris.com

(1) Antiallodynic Effects of Cannabinoid Receptor 2 (CB₂R) Agonists on Retrovirus Infection-Induced Neuropathic PainPain research & managementJanuary 1, 2019Sheng WS, Chauhan P, Hu S, Prasad S, Lokensgard JR.

(2) Altered Swimming Behaviors in Zebrafish Larvae Lacking Cannabinoid Receptor 2Cannabis and cannabinoid researchJanuary 1, 2019Acevedo-Canabal A, Colón-Cruz L, Rodriguez-Morales R, Varshney GK, Burgess S, González-Sepúlveda L, Yudowski G, Behra M.

(3) Pro-inflammatory obesity in aged cannabinoid-2 receptor-deficient miceInternational journal of obesity (2005)February 1, 2016Schmitz K, Mangels N, Häussler A, Ferreirós N, Fleming I, Tegeder I.

(4) Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in MacrophagesPloS oneJanuary 1, 2016Ke P, Shao BZ, Xu ZQ, Wei W, Han BZ, Chen XW, Su DF, Liu C.

(5) Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonistPharmacology research & perspectivesAugust 1, 2015Presley C, Abidi A, Suryawanshi S, Mustafa S, Meibohm B, Moore BM.

(6) Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonistsBioorganic & medicinal chemistryJanuary 1, 2015Gianella-Borradori M, Christou I, Bataille CJ, Cross RL, Wynne GM, Greaves DR, Russell AJ.

(7) The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cellsThe Journal of biological chemistryMay 9, 2014Wilhelmsen K, Khakpour S, Tran A, Sheehan K, Schumacher M, Xu F, Hellman J.

(8) Experimental cannabinoid 2 receptor-mediated immune modulation in sepsisMediators of inflammationJanuary 1, 2014Sardinha J, Kelly ME, Zhou J, Lehmann C.

(9) Prospects for cannabinoid therapies in viral encephalitisBrain researchNovember 6, 2013Solbrig MV, Fan Y, Hazelton P.

Be the First to Write a Review!